| Drug Name | Palbociclib |
|---|---|
| Other Drug Names | Ibrance; PD-0332991; PD-332991; PD-991; PF-332991 |
| Chemical Name | 6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one |
| Formula | C24H29N7O2 |
| Mol. Wt. | 447.5401 |
| CAS No. | 571190-30-2 |
| UNII | G9ZF61LE7G |
| Target-based Actions | Cyclin-dependent kinase-4 inhibitor; Cyclin-dependent kinase-6 inhibitor; Retinoblastoma associated protein modulator |
| ATC Codes | L01XE33 |
| Highest Status | 2015年批准上市 |
| Originator Company | Pfizer Inc. |
| Structure |
 |